Cecilia Jones, CFO of Agios Pharmaceuticals ($AGIO), sold shares on the open market seven times over the past year for a total of $419,190. Her most recent sale occurred on March 2, 2026. These transactions rank her 6,846th among 11,678 insiders by sale value, well below the average of $8.6 million per seller and 6.4 transactions. Jones made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | A | Restricted stock units | 14000 | $0.00 | 14,000.0000 | 74,665,003 | 9999.99% | 0.02% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 1573 | $28.96 | 49,328.0000 | 74,665,003 | 3.09% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 5303 | $0.00 | 50,901.0000 | 74,665,003 | 11.63% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 5666 | $0.00 | 44,466.0000 | 74,665,003 | 14.60% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 594 | $28.96 | 38,800.0000 | 74,665,003 | 1.51% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 2000 | $0.00 | 39,394.0000 | 74,665,003 | 5.35% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Restricted stock units | 5666 | $0.00 | 5,667.0000 | 74,665,003 | 50.00% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Restricted stock units | 2000 | $0.00 | 0.0000 | 74,665,003 | 100.00% | 0.00% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | A | Stock options (right to buy) | 52000 | $0.00 | 52,000.0000 | 74,665,003 | 9999.99% | 0.07% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 1681 | $28.96 | 42,785.0000 | 74,665,003 | 3.78% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 4000 | $0.00 | 46,785.0000 | 74,665,003 | 9.35% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 1187 | $28.96 | 45,598.0000 | 74,665,003 | 2.54% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Restricted stock units | 5303 | $0.00 | 10,607.0000 | 74,665,003 | 33.33% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Restricted stock units | 4000 | $0.00 | 8,000.0000 | 74,665,003 | 33.33% | 0.01% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Performance share units | 6000 | $0.00 | 0.0000 | 74,496,287,000 | 100.00% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 2932 | $27.09 | 37,394.0000 | 74,496,287,000 | 7.27% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 6000 | $0.00 | 40,326.0000 | 74,496,287,000 | 17.48% | 0.00% |
| Sept. 26, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 7472 | $0.00 | 37,521.0000 | 74,254,956,000 | 24.87% | 0.00% |
| Sept. 26, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 3651 | $36.77 | 33,870.0000 | 74,254,956,000 | 9.73% | 0.00% |
| Sept. 26, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Restricted stock units | 7472 | $0.00 | 0.0000 | 74,254,956,000 | 100.00% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 1780 | $33.54 | 30,049.0000 | 74,103,192,000 | 5.59% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Performance share units | 6000 | $0.00 | 6,000.0000 | 74,103,192,000 | 50.00% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 6000 | $0.00 | 31,829.0000 | 74,103,192,000 | 23.23% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 1681 | $35.54 | 25,829.0000 | 73,372,696,000 | 6.11% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 2000 | $0.00 | 22,437.0000 | 73,372,696,000 | 9.79% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 594 | $35.54 | 21,843.0000 | 73,372,696,000 | 2.65% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 5667 | $0.00 | 27,510.0000 | 73,372,696,000 | 25.94% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | A | Restricted stock units | 12000 | $0.00 | 12,000.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | A | Restricted stock units | 15910 | $0.00 | 15,910.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | A | Stock options (right to buy) | 43500 | $0.00 | 43,500.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Restricted stock units | 2000 | $0.00 | 2,000.0000 | 73,372,696,000 | 50.00% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Restricted stock units | 5667 | $0.00 | 11,333.0000 | 73,372,696,000 | 33.34% | 0.00% |
| Sept. 26, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Restricted stock units | 7473 | $0.00 | 7,472.0000 | 73,091,490,000 | 50.00% | 0.00% |
| Sept. 26, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 2542 | $49.03 | 20,158.0000 | 73,091,490,000 | 11.20% | 0.00% |
| Sept. 26, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 7473 | $0.00 | 22,700.0000 | 73,091,490,000 | 49.08% | 0.00% |
| March 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 672 | $32.57 | 14,840.0000 | 72,161,489,000 | 4.33% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | A | Restricted stock units | 17000 | $0.00 | 17,000.0000 | 72,161,489,000 | 9999.99% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | A | Stock options (right to buy) | 60000 | $0.00 | 60,000.0000 | 72,161,489,000 | 9999.99% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Restricted stock units | 2000 | $0.00 | 4,000.0000 | 72,161,489,000 | 33.33% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 2000 | $0.00 | 15,512.0000 | 72,161,489,000 | 14.80% | 0.00% |
| Jan. 24, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 1886 | $21.64 | 13,069.0000 | 72,161,489,000 | 12.61% | 0.00% |
| Jan. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Performance share units | 5380 | $0.00 | 0.0000 | 72,161,489,000 | 100.00% | 0.00% |
| Jan. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 5380 | $0.00 | 14,955.0000 | 72,161,489,000 | 56.19% | 0.00% |
| Sept. 26, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 7472 | $0.00 | 11,754.0000 | 71,256,118 | 174.50% | 0.01% |
| Sept. 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 2179 | $24.79 | 9,575.0000 | 71,256,118 | 18.54% | 0.00% |
| Sept. 26, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Restricted stock units | 7472 | $0.00 | 14,945.0000 | 71,256,118 | 33.33% | 0.01% |
| June 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Performance share units | 5380 | $0.00 | 5,380.0000 | 71,256,118 | 50.00% | 0.01% |
| June 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | M | Common stock | 5380 | $0.00 | 5,380.0000 | 71,256,118 | 9999.99% | 0.01% |
| June 30, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | S | Common stock | 1597 | $28.36 | 3,783.0000 | 71,256,118 | 29.68% | 0.00% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | A | Stock options (right to buy) | 22000 | $0.00 | 22,000.0000 | 71,256,118 | 9999.99% | 0.03% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Jones Cecilia | Chief Financial Officer | A | Restricted stock units | 6000 | $0.00 | 6,000.0000 | 71,256,118 | 9999.99% | 0.01% |